While certain markers and drivers of T-cell exhaustion seen in tumor infiltrates (TILS) have been well studied in the past decade [8,10,23,24], most findings are limited to CD8+ subtypes, leaving unanswered questions if these observations carry over to their CD4+ T-cell counterparts. The gene discussed is CD4; the disease is neoplasm.